Author/Authors :
Habrand، نويسنده , , J.L. and Haie-Meder، نويسنده , , C. and Rey، نويسنده , , A. and Mammar، نويسنده , , H. and Pontvert، نويسنده , , D. and Gaboriaud، نويسنده , , G. and Couanet، نويسنده , , D. and Lenir، نويسنده , , C. and Valinta، نويسنده , , D. and Ferrand، نويسنده , , R. and Boisserie، نويسنده , , G. and Beaudré، نويسنده , , A. and Kerody، نويسنده , , K. and Mazal، نويسنده , , A. and Dupouy، نويسنده , , N. and Bonomi، نويسنده , , M. and M، نويسنده ,
Abstract :
SummaryPurpose
ctober 1993 through July 1998, 48 assessable adult patients with non-resectable aggressive intracranial tumors were treated by a combination of high dose photon + proton therapy at the Centre de Protonthérapie dʹOrsay.
ts and methods
1 and 4 gliomas were excluded. Patients benefited from a 3D dose calculation based on high-definition CT and MRI, a stereotactic positioning using implanted fiducial markers and a thermoplastic mask. Mean tumor dose ranged between 63 and 67 Gy delivered in five weekly sessions of 1.8 Gy in most patients, according to the histological types (doses in Co Gy Equivalent, with a mean proton-RBE of 1.1).
s
median 18-month follow-up (range: four-58 months), local control in tumors located in the envelopes and in the skull base was 97% (33/34), and in parenchymal tumors, 43% (6/14) only. Two patients (5%) presented with a clinically severe radiation-induced necrosis (temporal lobe and chiasm).
sion
experience, high-dose radiation combining photons and protons is a safe and highly efficient procedure in selected malignancies of the skull base and envelopes.
Keywords :
adultes , Protonthérapie , Système nerveux central , adults , Central nervous system , Proton therapy